Search Results - "Postma, D. F."

Refine Results
  1. 1
  2. 2

    The immunomodulatory effects of statins in community-acquired pneumonia: A systematic review by Troeman, D.P.R, Postma, D.F, van Werkhoven, C.H, Oosterheert, J.J

    Published in The Journal of infection (01-08-2013)
    “…Summary Objective To evaluate the potential immunomodulatory effects of statins in community-acquired pneumonia. Methods We performed a systematic review of…”
    Get full text
    Journal Article
  3. 3

    New trends in the prevention and management of community-acquired pneumonia by POSTMA, D. F, VAN WERKHOVEN, C. H, HUIJTS, S. M, BOLKENBAAS, M, OOSTERHEERT, J. J, BONTEN, M. J. M

    Published in Netherlands journal of medicine (01-10-2012)
    “…Community-acquired pneumonia (CAP) is an important cause of morbidity and mortality worldwide. This review summarises current trends and knowledge gaps in CAP…”
    Get full text
    Journal Article
  4. 4

    Circulating monocytes expressing senescence‐associated features are enriched in COVID‐19 patients with severe disease by Lin, Y., Postma, D. F., Steeneken, L. S., Melo dos Santos, L. S., Kirkland, J. L., Espindola‐Netto, J. M., Tchkonia, T., Borghesan, M., Bouma, H. R., Demaria, M.

    Published in Aging cell (01-12-2023)
    “…Accurate biomarkers for predicting COVID‐19 severity have remained an unmet need due to an incomplete understanding of virus pathogenesis and heterogeneity…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to compare strategies to optimize antibiotic use by Schweitzer, V.A., van Smeden, M., Postma, D.F., Oosterheert, J.J., Bonten, M.J.M., van Werkhoven, C.H.

    Published in Clinical microbiology and infection (01-12-2017)
    “…The Response Adjusted for Days of Antibiotic Risk (RADAR) statistic was proposed to improve the efficiency of trials comparing antibiotic stewardship…”
    Get full text
    Journal Article
  8. 8

    Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients by Simonetti, A.F., van Werkhoven, C.H., Schweitzer, V.A., Viasus, D., Carratalà, J., Postma, D.F., Oosterheert, J.J., Bonten, M.J.M.

    Published in Clinical microbiology and infection (01-10-2017)
    “…Our objective was to identify clinical predictors of antibiotic treatment effects in hospitalized patients with community-acquired pneumonia (CAP) who were not…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Screening for asymptomatic deep vein thrombosis in COVID-19 patients admitted to the medical ward: a cross-sectional study by Olgers, T. J., Lieveld, A. W. E., Kok, B., Heijmans, J., Salet, D., Assman, N. L., Postma, D. F., Bauer, M. P., Nanayakkara, P. W. B., Meijer, K., Bosch, F. H., Kooistra, H.

    Published in Journal of ultrasound (01-03-2023)
    “…Purpose Patients with COVID-19 have an increased risk for venous thrombo-embolism (VTE), especially pulmonary embolism. The exact prevalence of asymptomatic…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands by Schweitzer, V A, van Werkhoven, C H, van Heijl, I, Smits, R F, Boel, C H E, Bonten, M J M, Postma, D F, Oosterheert, J J

    Published in Netherlands journal of medicine (01-11-2018)
    “…There is no consensus whether patients with healthcare-associated pneumonia (HCAP) should be considered as a patient with hospital-acquired pneumonia (HAP) and…”
    Get full text
    Journal Article
  13. 13

    Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial by van Werkhoven, C H, Postma, D F, Oosterheert, J J, Bonten, M J M

    Published in Netherlands journal of medicine (01-04-2014)
    “…For the empirical treatment of community-acquired pneumonia requiring admission to a non-ICU ward, the Dutch guidelines recommend either beta-lactam…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding by Struijk, M, Postma, D.F, van Tuyl, S.A.C, van de Ree, M.A

    Published in European journal of internal medicine (01-04-2012)
    “…Abstract Upper gastrointestinal bleeding is a common adverse effect of chronic aspirin treatment. Traditionally, most physicians might tend to discontinue…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20